CHLOE MARTIN: Open Payments
NPI 1467992511 · JOHNSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 48 payments from 9 companies in 2025. Trend: 2023 $567 · 2024 $896 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $305 |
| ABBVIE INC. | 20 | $211 |
| Novo Nordisk Inc | 7 | $164 |
| Amgen Inc. | 5 | $83 |
| Exact Sciences Corporation | 3 | $65 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Lilly USA, LLC | 1 | $22 |
| Verity Pharmaceuticals Inc. | 1 | $17 |
| TOLMAR, INC. | 1 | $15 |
Products named: AIRSUPRA, VRAYLAR, Ozempic, OTEZLA, FARXIGA, Cologuard Collection Kit, TRELEGY ELLIPTA, Rybelsus.
Industry payments across SC — which companies pay providers there.
